Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/24/24
End: 09/09/24
Due: 09/09/25
Phase: N/A
Priority: Normal
Start: 12/01/22
End: 05/30/23
Due: 05/30/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Phase 1b Study to Evaluate the Safety of XEN-101 | NCT06417697 | Xeno Biosciences | user2@example.com | None | 2024-05-24 | 2024-09-09 | 2025-09-09 | - | - | 2025-07-14 |
| A Phase 1 Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of XEN-101 | NCT05667129 | Xeno Biosciences | user2@example.com | None | 2022-12-01 | 2023-05-30 | 2024-05-30 | - | - | 2025-07-14 |